Literature DB >> 17321645

The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken.

Dimitrios Dilaveris1, Changlin Chen, Pete Kaiser, Peter H Russell.   

Abstract

Newcastle disease virus is a major threat to poultry and in ovo vaccines are needed. A live in ovo vaccine for Newcastle disease virus, which was licensed but not marketed, was unsafe. It killed 32% of line 0 chicks and 10% of vaccine Lohmann (VALO) chicks using the maximum recommended dose that infected about 40% of the embryos. VALO's made more antibody than line 0's whether infected in ovo or by contact. The vaccine interrupted the massive development of the air capillaries between injection and hatch 3 days later. Cytokines, delivered as DNA in plasmids, did not function as adjuvants. IFN-gamma prevented infection. IL-4 or IL-18 had little or no effect. Line 0 chicks that had been infected by contact were protected and so the unsafe in ovo vaccination of a minority could protect the majority.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321645     DOI: 10.1016/j.vaccine.2007.01.115

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  The Diverse Major Histocompatibility Complex Haplotypes of a Common Commercial Chicken Line and Their Effect on Marek's Disease Virus Pathogenesis and Tumorigenesis.

Authors:  Luca D Bertzbach; Clive A Tregaskes; Rebecca J Martin; Undine-Sophie Deumer; Lan Huynh; Ahmed M Kheimar; Andelé M Conradie; Jakob Trimpert; Jim Kaufman; Benedikt B Kaufer
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

2.  Evaluation of a thermostable Newcastle disease virus strain TS09-C as an in-ovo vaccine for chickens.

Authors:  Guoyuan Wen; Lintao Li; Qingzhong Yu; Hongling Wang; Qingping Luo; Tengfei Zhang; Rongrong Zhang; Wanpo Zhang; Huabin Shao
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.